by Robert Garment
, Executive Editor | April 12, 2006
Kodak is a leader
in PACS -- Picture Archiving
ROCHESTER, N.Y., April 11 -- Eastman Kodak Company today announced that it has received clearance from the Food and Drug Administration (FDA) for several specialized functions that enable radiologists to diagnose images generated by non-invasive cardiac scanning methods. These specialized functions--cardiac review and analysis; cardiac cage removal in 3D imaging and cardiac calcium scoring--are being integrated into the next version of KODAK CARESTREAM PACS Software.
These functions, which equip radiologists to analyze cardiac CT (computed tomography) imaging exams, will be commercially available in the newest version of KODAK PACS software scheduled for release in mid-2006.
Cardiac review and analysis provides four-chamber and cross-sectional views of the heart axis and panoramic and cross-sectional views of cardiac vessels such as the left main artery (LMA), right coronary artery (RCA), left circumflex artery (LCX), and posterior descending artery.
The calcium scoring module analyzes calcified plaque in five main blood vessels of the heart, while the cage removal function removes anatomy around the heart not required for cardiac viewing.
Kodak also received FDA clearance for bone removal (to enhance viewing of other structures) and vessel analysis enhancements (including extended stenosis marking) that are used with CT exams of arteries and veins throughout the body.
All of these features are part of Kodak's native, real-time 3D capabilities that also include MIP (maximum intensity projection), MinIP (minimum intensity projection), MPR (multiplanar reconstruction), volume rendering, tissue definition, and vessel tracking functionality.